JDVFX
Price
$24.78
Change
-$0.07 (-0.28%)
Updated
Sep 3 closing price
Net Assets
18.42B
RMFCX
Price
$60.11
Change
-$0.10 (-0.17%)
Updated
Sep 3 closing price
Net Assets
109.45B
Interact to see
Advertisement

JDVFX vs RMFCX

Header iconJDVFX vs RMFCX Comparison
Open Charts JDVFX vs RMFCXBanner chart's image
JHancock Disciplined Value R4
Price$24.78
Change-$0.07 (-0.28%)
VolumeN/A
Net Assets18.42B
American Funds American Mutual R3
Price$60.11
Change-$0.10 (-0.17%)
VolumeN/A
Net Assets109.45B
JDVFX vs RMFCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JDVFX vs. RMFCX commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JDVFX is a Buy and RMFCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 109B vs. JDVFX (18.4B). RMFCX pays higher dividends than JDVFX: RMFCX (1.24) vs JDVFX (0.79). JDVFX was incepted earlier than RMFCX: JDVFX (16 years) vs RMFCX (23 years). JDVFX (0.96) is less costly to investors than RMFCX (0.91). JDVFX is a more actively managed with annual turnover of: 63.00 vs. RMFCX (31.00). JDVFX has a lower initial minimum investment than RMFCX: JDVFX (0) vs RMFCX (250). RMFCX annual gain was more profitable for investors over the last year : 6.48 vs. JDVFX (-0.53). RMFCX return over 5 years is better than : 55.53 vs. JDVFX (40.01).
JDVFXRMFCXJDVFX / RMFCX
Total Expense Ratio0.850.9193%
Annual Report Gross Expense Ratio0.960.91105%
Fund Existence16 years23 years-
Gain YTD10.59210.79598%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets18.4B109B17%
Annual Yield % from dividends0.791.2464%
Returns for 1 year-0.536.48-8%
Returns for 3 years17.6130.9857%
Returns for 5 years40.0155.5372%
Returns for 10 years50.1494.4353%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTMX2.120.04
+1.92%
CytomX Therapeutics
WINA463.167.15
+1.57%
Winmark Corp
LGCL0.51N/A
-0.60%
Lucas GC Limited
GRFS9.59-0.09
-0.93%
Grifols SA
ALDFU10.50-0.50
-4.55%
Aldel Financial II Inc